Treating Ebola in eastern DRC

The Lancet Infectious Diseases

Volumn 19, Issue 10, 2019, Pages 1059-1060

  Fedson, David S ^a  

^a Sergy Haut   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; MONOCLONAL ANTIBODY;

CASE FATALITY RATE; DEMOCRATIC REPUBLIC CONGO; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; SIERRA LEONE; SURVIVAL; EPIDEMIC;

DEMOCRATIC REPUBLIC OF THE CONGO; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 85072536431     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(19)30484-0     Document Type: Letter

References (5)

1. Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA. The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018–2019. N Engl J Med 2019; 381: 373–83.
2. Rollin PE. Ebola in eastern DRC. Lancet Infect Dis 2019; 19: 1049–50.
3. McNeil DG Jr. A cure for Ebola? Two new treatments prove highly effective in Congo. The New York Times, Aug 12, 2019.
4. Fedson DS. Treating the host response to emerging virus diseases: lesson learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med 2016; 4: 421.
5. Baddeley M. Herding, social influences and behavioural bias in scientific research. EMBO Rep 2015; 16: 902–05.